---
$id: https://graph.org.ai/products/commodity/51111652
$type: Product
source: UNSPSC
code: "51111652"
title: "Piritrexim"
class: "51111600"
classTitle: "Antimetabolites"
family: "51110000"
familyTitle: "Antineoplastic agents"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Piritrexim

**UNSPSC Code**: 51111652
**Class**: [Antimetabolites](Antimetabolites.mdx)
**Family**: [Antineoplastic agents](../Antineoplastic agents.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a folate antagonist and dihydrofolate reductase inhibitor with the molecular formula C17H19N5O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier, MK2A783ZUT chemically known as 2,4-diamino-6-(2,5-dimethoxybenzyl)-5-methylpyrido(2,3-d)pyrimidine but generally known as piritrexim, which bears US NIH Compound Identifier 54369. European Medicines Agency schedules Piritrexim in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09921MIG. The term PIRITREXIM is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 40, no. 6, 1986, list 26). Most nations schedule piritrexim under HS 29335995 and SITC 51576. As of Q4 2014, PIRITREXIM remains the US FDA Preferred Term for this commodity. Piritrexim bears US NLM identifiers UMLS ID C0054332 and NCI Concept Code C1031. SMILES: CC1=C2C(=NC(=NC2=NC=C1CC3=C(C=CC(=C3)OC)OC)N)N.

